Stockscreener 앱 받기
2.3902
147.51%
1.4401
전일 마감가:
$0.9501
열려 있는:
$1.1
하루 거래량:
33.58M
Relative Volume:
87.84
시가총액:
$11.81M
수익:
-
순이익/손실:
$-39.62M
주가수익비율:
-0.00144
EPS:
-1654.3275
순현금흐름:
$-17.96M
1주 성능:
+123.96%
1개월 성능:
+4.53%
6개월 성능:
-95.37%
1년 성능:
-99.68%
1일 변동 폭
$1.0681
$2.89
1주일 범위
$0.7932
$2.89
52주 변동 폭
$0.7932
$848.00
Cdt Equity Inc Stock (CDT) Company Profile
명칭
Cdt Equity Inc
전화
(646) 491 9132
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
2.4299 | 4.62M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
447.75 | 113.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
615.80 | 65.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
833.86 | 52.14B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
299.46 | 40.73B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.19 | 32.87B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc 주식(CDT)의 최신 뉴스
CDT Faces Nasdaq Compliance Notice Due to Filing Delay - GuruFocus
CDT Equity receives Nasdaq notice over delayed quarterly filing - MSN
CDT Equity Receives Nasdaq Notice Over Late Filing - TipRanks
CDT Equity Inc. Receives Nasdaq Deficiency Letter for Non-Compliance - geneonline.com
CDT Equityhas until July 20, 2026 to submit Nasdaq compliance plan - marketscreener.com
Nasdaq warns CDT Equity (CDT) over delayed Form 10-Q but trading continues - Stock Titan
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - marketscreener.com
Nasdaq flags CDT Equity for missed quarterly 10-Q filing - Stock Titan
CDTTW Warrants Remain at Floor Level – CDT Equity Inc. (CDTTW) Shows No Price MovementArms Index - The Legal Advocate
CDTTW Warrants Trade Flat at $0.01 Amidst Minimal ActivityEase of Movement - newsline.com
CDT Equity receives Canadian patent for male infertility drug - Investing.com
CDT Equity receives Canadian patent for male infertility drug By Investing.com - Investing.com South Africa
No approved drugs for male infertility — but CDT just secured a key patent - Stock Titan
CDT Equity Company Profile & Introduction - Moomoo
CDT Equity Inc. (CDT) Plunges 14% as Selling Pressure Intensifies Below $1.10 ResistanceNaked POC - Newser
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
Nirland-controlled group reports 75,315 CDT shares (NASDAQ: CDT) - Stock Titan
Equity Inc (CDT) Stock Analysis: Climbs +3.33%, Eyes on $1.30 2026-05-20Social Trading Insights - Newser
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market SessionAIM ImmunoTech (AMEX:AIM), Atlantic Inter - Benzinga
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
Corvus updates CDT Equity (CDT) ownership to about a 5.4% stake - Stock Titan
CEO-linked entities of CDT Equity (CDT) add shares, exercise warrants - Stock Titan
Number of shareholders of CDT Equity Inc. – NASDAQ:CDT - TradingView
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - Yahoo Finance
CDT SEC FilingsCDT Equity 10-K, 10-Q, 8-K Forms - Stock Titan
CDT Equity Inc shares plunge 7.96% as Q1 2026 shows zero revenue and massive loss.EBIT Margin - Newser
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - The Manila Times
A patent filed in under 3 weeks puts CDT's Sarborg stake in focus - Stock Titan
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - AI Magazine
After 181-subject safety studies, CDT seeks partner for infertility drug - Stock Titan
[EFFECT] CDT Equity Inc. SEC Filing - Stock Titan
5.35M CDT Equity (NASDAQ: CDT) shares registered for resale by selling holders - Stock Titan
CDT Equity (CDT) director discloses 233,585 Common Stock shares on Form 3 - Stock Titan
CDT - Finviz
CDTTW (CDT Warrant) leadership outlines long-term growth priorities as latest quarterly earnings figures remain undisclosed.Recovery Report - newser.com
CDT Equity Announces Board Changes and New Chairperson - The Globe and Mail
New LowStock ScreenerSnapshot - Finviz
CDT Equity announces reverse stock split - MSN
Board reshuffle at CDT Equity (NASDAQ: CDT) adds Ulrik Olsen, new chairs - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Conduit to change name to CDT Equity - MSN
Cdt Equity Inc (CDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
2.80%
자본화:
|
볼륨(24시간):